Express News | News On Nabriva Therapeutics PLC (NBRV) Now Under NBRVF

Moomoo 24/7Aug 1, 2023 17:08 ET

Arbutus Biopharma Appoints Karen Sims as Chief Medical Officer

Seeking AlphaJul 11, 2023 03:46 ET

Arbutus Biopharma Promotes Dr. Karen Sims to Chief Medical Officer, Hires Christopher Naftzger as Chief Compliance Officer

MT NewswiresJul 10, 2023 16:48 ET

BE, OUST and RIGL Are Among Pre Market Gainers

Seeking AlphaMay 19, 2023 08:20 ET

As Part Of Nabriva Therapeutics' Cash Preservation Plan, The Company's Board Decided To Terminate All Non-Essential Employees To Execute The Wind-down Of Its Operations; Nabriva Said It Largely Completed The Planned Workforce Reduction In Q1 2023

BenzingaMay 15, 2023 17:26 ET

Nabriva Therapeutics (NASDAQ:NBRV) Now Covered by StockNews.com

kopsourceApr 11, 2023 01:53 ET